Jagsonpal Pharmaceuticals Limited (BOM:507789)
India flag India · Delayed Price · Currency is INR
174.25
-4.90 (-2.74%)
At close: Feb 13, 2026

Jagsonpal Pharmaceuticals Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
553.61224.63267.21188.55170.58
Depreciation & Amortization
81.3116.6311.7515.2610.86
Loss (Gain) From Sale of Assets
-233.59--3.59-0.85-
Asset Writedown & Restructuring Costs
1.75-28.09--
Loss (Gain) From Sale of Investments
---1.48-11.362.51
Stock-Based Compensation
68.04133.187.65--
Provision & Write-off of Bad Debts
-7.672.620.42-
Other Operating Activities
26.64-85.76-20.66-8.33-17.67
Change in Accounts Receivable
-22.2591.54-55.56-29.5587.89
Change in Inventory
0.0153.186.86-0.18-4
Change in Accounts Payable
21.38-89.82-19.62-10.7563.41
Change in Income Taxes
-----92.92
Change in Other Net Operating Assets
56.10.5783.28-74.07-57.92
Operating Cash Flow
553351.66466.5569.14282.22
Operating Cash Flow Growth
57.25%-24.63%574.79%-75.50%137.46%
Capital Expenditures
-3.48-2.48-3.18-10.49-4.69
Sale of Property, Plant & Equipment
357.18-12.965.81-
Cash Acquisitions
-936.57----
Investment in Securities
53-316.67-620.77-268.57-41.73
Other Investing Activities
78.473.6734.2815.4623.78
Investing Cash Flow
-451.47-245.48-576.71-257.79-22.64
Long-Term Debt Repaid
-9.02-6.33-0.44-67.88-
Total Debt Repaid
-9.02-6.33-0.44-67.88-
Net Debt Issued (Repaid)
-9.02-6.33-0.44-67.88-
Issuance of Common Stock
33.9156.35---
Repurchase of Common Stock
-----36.95
Common Dividends Paid
-132.29-130.99--104.79-26.2
Other Financing Activities
-9.58-8.14-4.13-2.85-5.14
Financing Cash Flow
-116.98-89.11-4.57-175.52-68.28
Net Cash Flow
-15.4517.07-114.73-364.17191.3
Free Cash Flow
549.52349.18463.3758.65277.53
Free Cash Flow Growth
57.37%-24.64%690.06%-78.87%176.69%
Free Cash Flow Margin
20.45%16.73%19.57%2.70%14.77%
Free Cash Flow Per Share
8.165.277.080.904.24
Cash Interest Paid
8.587.77-2.614.28
Cash Income Tax Paid
81.4385.1372.7668.7331.5
Levered Free Cash Flow
638.24197.59425.6249.28157.46
Unlevered Free Cash Flow
643.61202.44427.3650.92160.13
Change in Working Capital
55.2455.3994.96-114.55115.94
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.